Esperion Therapeutics Inc at Jefferies London Healthcare Conference Transcript
Good morning, everybody. My name is Dennis Ding, biotech analyst here at Jefferies. Welcome to the 2023 London Healthcare Conference. I have the great pleasure of having CEO, Sheldon Koenig of Esperion, here with us today. It's great to see you in person, Sheldon. And it's great to see all investors in the room this morning as well.
Questions & Answers
So maybe to level set all of those, just remind us of all the progress you guys have made this year and how you think about the outlook for bempedoic acid going forward.
Great. Thank you, Dennis. And not be rude, I'll look at the audience while I speak. First of all, I just want to thank Jefferies on behalf of all employees at Esperion for inviting us here to this conference.
And as related to bempedoic acid, as I was just saying to Dennis outside of the room, we're super excited of the progress that we've
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
